Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Chidamide Plus PTCy/Cyclosporine to Prevent GVHD After Myeloablative Conditioning, Matched PBSCT
- Status
- UNKNOWN
- Phase
- PHASE2
Carfilzomib, Cyclophosphamide, Dexamethasone in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Dose-Dense For Early Her2Neu Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of BCMA CAR-T in Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Chidamide Combined With PECM in Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
- Status
- UNKNOWN
- Phase
- PHASE2
T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Allogeneic Stem Cell Transplantation for Multiple Myeloma and Myelofibrosis
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
- Status
- UNKNOWN
- Phase
- NA
Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Adoptive Cell Therapy Across Cancer Diagnoses
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBC
- Status
- COMPLETED
- Phase
- PHASE2
TIL Therapy in Combination With Checkpoint Inhibitors for Metastatic Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2